These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 34955792)

  • 1. Association Between Z Drugs Use and Risk of Cognitive Impairment in Middle-Aged and Older Patients With Chronic Insomnia.
    Guo F; Yi L; Zhang W; Bian ZJ; Zhang YB
    Front Hum Neurosci; 2021; 15():775144. PubMed ID: 34955792
    [No Abstract]   [Full Text] [Related]  

  • 2. The prevalence and prescribing patterns of benzodiazepines and Z-drugs in older nursing home residents in different European countries and Israel: retrospective results from the EU SHELTER study.
    Lukačišinová A; Fialová D; Peel NM; Hubbard RE; Brkic J; Onder G; Topinková E; Gindin J; Shochat T; Gray L; Bernabei R
    BMC Geriatr; 2021 Apr; 21(1):277. PubMed ID: 33902474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Z-drugs and risk for falls and fractures in older adults-a systematic review and meta-analysis.
    Treves N; Perlman A; Kolenberg Geron L; Asaly A; Matok I
    Age Ageing; 2018 Mar; 47(2):201-208. PubMed ID: 29077902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The acute cognitive effects of zopiclone, zolpidem, zaleplon, and eszopiclone: a systematic review and meta-analysis.
    Stranks EK; Crowe SF
    J Clin Exp Neuropsychol; 2014; 36(7):691-700. PubMed ID: 24931450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of benzodiazepine and Z-drug use with the risk of hospitalisation for fall-related injuries among older people: a nationwide nested case-control study in Taiwan.
    Yu NW; Chen PJ; Tsai HJ; Huang CW; Chiu YW; Tsay WI; Hsu J; Chang CM
    BMC Geriatr; 2017 Jul; 17(1):140. PubMed ID: 28693443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contribution of prolonged-release melatonin and anti-benzodiazepine campaigns to the reduction of benzodiazepine and Z-drugs consumption in nine European countries.
    Clay E; Falissard B; Moore N; Toumi M
    Eur J Clin Pharmacol; 2013 Apr; 69(4):1-10. PubMed ID: 23114457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Benzodiazepines and Z-drug use among HIV-infected patients in Taiwan: a 13-year nationwide cohort study.
    Wei HT; Chen MH; Wong WW; Chou YH; Liou YJ; Su TP; Chen TJ; Bai YM
    Biomed Res Int; 2015; 2015():465726. PubMed ID: 25654104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In the Zzz zone: the effects of Z-drugs on human performance and driving.
    Gunja N
    J Med Toxicol; 2013 Jun; 9(2):163-71. PubMed ID: 23456542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drugs for Insomnia beyond Benzodiazepines: Pharmacology, Clinical Applications, and Discovery.
    Atkin T; Comai S; Gobbi G
    Pharmacol Rev; 2018 Apr; 70(2):197-245. PubMed ID: 29487083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New drugs for insomnia: comparative tolerability of zopiclone, zolpidem and zaleplon.
    Terzano MG; Rossi M; Palomba V; Smerieri A; Parrino L
    Drug Saf; 2003; 26(4):261-82. PubMed ID: 12608888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sedative Hypnotics and the Risk of Falls and Fractures in the Elderly.
    Andrade C
    J Clin Psychiatry; 2018; 79(3):. PubMed ID: 29873951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety of zaleplon in the treatment of insomnia.
    Israel AG; Kramer JA
    Ann Pharmacother; 2002 May; 36(5):852-9. PubMed ID: 11978165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insomnia in Elderly Patients: Recommendations for Pharmacological Management.
    Abad VC; Guilleminault C
    Drugs Aging; 2018 Sep; 35(9):791-817. PubMed ID: 30058034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the prescribing practices of nonbenzodiazepine, benzodiazepine receptor agonist hypnotics in adults at a federally qualified health center.
    Gray E; Bradley B
    J Am Pharm Assoc (2003); 2019; 59(4S):S146-S150. PubMed ID: 31248847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Orexin dual receptor antagonists, zolpidem, zopiclone, eszopiclone, and cognitive research: A comprehensive dose-response meta-analysis.
    Zhou M; Tang J; Li S; Li Y; Zhao M
    Front Hum Neurosci; 2022; 16():1029554. PubMed ID: 36699960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patient-centered care interventions to reduce the inappropriate prescription and use of benzodiazepines and z-drugs: a systematic review.
    Mokhar A; Topp J; Härter M; Schulz H; Kuhn S; Verthein U; Dirmaier J
    PeerJ; 2018; 6():e5535. PubMed ID: 30345166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Benzodiazepines and Related Drugs as a Risk Factor in Alzheimer's Disease Dementia.
    Ettcheto M; Olloquequi J; Sánchez-López E; Busquets O; Cano A; Manzine PR; Beas-Zarate C; Castro-Torres RD; García ML; Bulló M; Auladell C; Folch J; Camins A
    Front Aging Neurosci; 2019; 11():344. PubMed ID: 31969812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trends in the prescription of drugs used for insomnia: an open-cohort study in Australian general practice, 2011-2018.
    Begum M; Gonzalez-Chica D; Bernardo C; Woods A; Stocks N
    Br J Gen Pract; 2021 Nov; 71(712):e877-e886. PubMed ID: 33950853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trends in utilization of benzodiazepine and Z-drugs in Israel.
    Berman E; Eyal S; Marom E
    Pharmacoepidemiol Drug Saf; 2017 Dec; 26(12):1555-1560. PubMed ID: 29027336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trends in the consumption rates of benzodiazepines and benzodiazepine-related drugs in the health region of Lleida from 2002 to 2015.
    Torres-Bondia F; de Batlle J; Galván L; Buti M; Barbé F; Piñol-Ripoll G
    BMC Public Health; 2020 Jun; 20(1):818. PubMed ID: 32487058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.